Damian Garde is a Pharma Reporter at STAT News. He specializes in medicine and healthcare, with a focus on topics such as gene therapy, immunotherapy, oncology, and pancreatic cancer research. His work has been featured in prominent publications including The Boston Globe, Bloomberg News, and Fortune.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Damian Garde's coverage predominantly focuses on the healthcare and pharmaceutical industries, particularly biotechnology. He frequently cites data and press releases while also incorporating expert commentary.
To effectively engage Damian, offer insights backed by relevant data or provide access to industry experts who can offer nuanced perspectives on developments within the biotech, healthcare, and pharmaceutical sectors. Considering his focus on specific companies and deals, pitches should involve sources with direct knowledge of the events covered or deep expertise in similar occurrences within these industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Angus Chen, Damian Garde, Matthew Herper
We're here in San Diego, on the ground at AACR — one of the best places to spot early cancer research that will turn out to be important later on.
By: Matthew Herper, Damian Garde, Angus Chen
Dana-Farber study yielded strong results in 20 patients with smoldering multiple myeloma
By: Matthew Herper, Angus Chen, Damian Garde
You're reading the web version of STAT's popup newsletter, AACR in 30 seconds, your guide to what's happening at the American Association of Cancer Researchers' annual meeting. Sign up here
By: Angus Chen, Damian Garde, Matthew Herper
At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
By: Damian Garde, Angus Chen, Matthew Herper
In the meantime, thanks for joining us. Overcoming resistance and RevMed's next drug?
By: Elaine Chen, Damian Garde, Daniel Payne
Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.
There's a schism in America's drug business, playing out in punchy direct messages, feisty group chats, and the occasional heated in-person exchange.
By: Damian Garde
This story is republished from STAT , the health and medicine news site that's a partner to the Globe. Sign up for STAT's free Morning Rounds newsletter here
RFK Jr.'s list of Covid vaccine injuries, a father's quest to cure his daughter, and more health news from Morning Rounds
By: Damian Garde
German lawmakers passed a bill that would more than double the discount on branded medicines drugmakers must provide to the government,
